Chevy Chase Trust Holdings Inc. reduced its stake in shares of Laboratory Corp. of America Holdings (NYSE:LH) by 0.9% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 162,816 shares of the company’s stock after selling 1,560 shares during the period. Chevy Chase Trust Holdings Inc. owned 0.16% of Laboratory Corp. of America Holdings worth $22,384,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of LH. Robecosam AG boosted its stake in Laboratory Corp. of America Holdings by 23.1% in the second quarter. Robecosam AG now owns 800 shares of the company’s stock valued at $104,000 after buying an additional 150 shares in the last quarter. Smithfield Trust Co. acquired a new stake in Laboratory Corp. of America Holdings during the second quarter valued at approximately $107,000. Roble Belko & Company Inc acquired a new stake in Laboratory Corp. of America Holdings during the second quarter valued at approximately $117,000. Integrated Investment Consultants LLC boosted its stake in Laboratory Corp. of America Holdings by 56.3% in the second quarter. Integrated Investment Consultants LLC now owns 938 shares of the company’s stock valued at $122,000 after buying an additional 338 shares in the last quarter. Finally, Acrospire Investment Management LLC boosted its stake in Laboratory Corp. of America Holdings by 56.7% in the second quarter. Acrospire Investment Management LLC now owns 1,105 shares of the company’s stock valued at $144,000 after buying an additional 400 shares in the last quarter. Hedge funds and other institutional investors own 91.47% of the company’s stock.

Institutional Ownership by Quarter for Laboratory Corp. of America Holdings (NYSE:LH)

Shares of Laboratory Corp. of America Holdings (NYSE:LH) opened at 126.00 on Friday. The stock has a market capitalization of $12.98 billion, a price-to-earnings ratio of 19.98 and a beta of 0.96. Laboratory Corp. of America Holdings has a one year low of $97.79 and a one year high of $141.32. The company’s 50 day moving average price is $132.66 and its 200 day moving average price is $132.78.

Laboratory Corp. of America Holdings (NYSE:LH) last issued its earnings results on Wednesday, October 26th. The company reported $2.25 EPS for the quarter, missing the consensus estimate of $2.29 by $0.04. The business had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.38 billion. Laboratory Corp. of America Holdings had a net margin of 6.85% and a return on equity of 16.97%. The business’s revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.07 EPS. On average, analysts expect that Laboratory Corp. of America Holdings will post $8.79 earnings per share for the current fiscal year.

A number of equities analysts have issued reports on LH shares. Zacks Investment Research raised Laboratory Corp. of America Holdings from a “hold” rating to a “buy” rating and set a $153.00 price target for the company in a research note on Tuesday, October 4th. KeyCorp increased their price target on Laboratory Corp. of America Holdings from $143.00 to $150.00 and gave the company an “overweight” rating in a research note on Tuesday, August 16th. Barclays PLC set a $155.00 price target on Laboratory Corp. of America Holdings and gave the company a “buy” rating in a research note on Monday, August 29th. Evercore ISI increased their price target on Laboratory Corp. of America Holdings from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Wednesday, July 27th. Finally, SunTrust Banks Inc. reaffirmed a “buy” rating on shares of Laboratory Corp. of America Holdings in a research note on Thursday, July 28th. Eight research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $143.13.

About Laboratory Corp. of America Holdings

Laboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

5 Day Chart for NYSE:LH

Receive News & Stock Ratings for Laboratory Corp. of America Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corp. of America Holdings and related stocks with our FREE daily email newsletter.